Tender Details

RT Ref.	2690728
Summary	Structured Product Labeling (SPL) HT9426-26-Q-E022
Tender Purchaser	View Full Details
Bid Submit Contact Details	View Full Details
Country	United States
Detailed Description	Structured Product Labeling (SPL) HT9426-26-Q-E022 Office of Regulated Activities of the DHA R&D – Medical Research and Development Command (MRDC) has a requirement to manage, process, and complete initial labeling and labeling changes in electronic structured product label document submissions to the FDA. Structured Product Labeling (SPL) is a Health Level Seven (HL7) standard based on Clinical Document Architecture and HL7 Reference Information Model (RIM) accredited by the American National Standards Institute (ANSI) for the exchange of product information. The DHA R&D – MRDC currently has 2 licensed New Drug Application (NDA) products which require SPL submissions for up to 5 levels of primary and secondary labeling.
Tender Notice No.	View Full Details
Deadline	June 29, 2026
Document Download	Download Documents
Purchase this Tender	OR Become Member Here